ProKidney Corp
PROK2.890USD
+0.080+2.85%
收盤 11/07, 16:00（美東）報價延遲15分鐘
385.58M總市值
虧損本益比TTM
關於 ProKidney Corp 公司
ProKidney Corp. 是一家臨牀階段的生物技術公司。該公司專注於細胞治療平臺，該平臺能夠使用從患者身上分離出來的細胞來治療多種慢性腎臟疾病 (CKD)。該公司的主要候選產品腎自體細胞療法 (REACT) 旨在保留 CKD 患者患病腎臟的腎功能。REACT 是一種產品，包括從患者自身（自體）腎細胞製備的自體選擇腎細胞 (SRC)。REACT 注射劑是一種研究性療法，是從參與者自身腎臟組織製備的腎細胞混合物。其專利技術包括細胞治療產品的製造和醫療輸送方面的多項突破。該公司正在針對中度至重度糖尿病腎病 (DKD) 患者開展 REACT 的全球 3 期開發計劃和多項 2 期臨牀試驗。
ProKidney Corp簡介
公司代碼PROK
公司名稱ProKidney Corp
上市日期Jun 30, 2021
CEODr. Bruce Culleton, M.D.
員工數量204
證券類型Ordinary Share
年結日Jun 30
公司地址2000 Frontis Plaza Blvd.
城市WINSTON-SALEM
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編27103
電話13369997028
網址https://prokidney.com/
公司代碼PROK
上市日期Jun 30, 2021
CEODr. Bruce Culleton, M.D.
ProKidney Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. Ethan Holdaway
Mr. Ethan Holdaway
Investor Relations
Investor Relations
--
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Mr. Pablo Legorreta
Mr. Pablo Legorreta
Chairman of the Board
Chairman of the Board
--
--
Dr. Uma Sinha, Ph.D.
Dr. Uma Sinha, Ph.D.
Independent Director
Independent Director
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Independent Director
Independent Director
--
--
Dr. Alan M. Lotvin, M.D.
Dr. Alan M. Lotvin, M.D.
Independent Director
Independent Director
--
--
Dr. Darin J. Weber, Ph.D.
Dr. Darin J. Weber, Ph.D.
Chief Regulatory Officer, Senior Vice President- Global Regulatory, Quality Management & Commercial
Chief Regulatory Officer, Senior Vice President- Global Regulatory, Quality Management & Commercial
--
--
Dr. Brian J. G. Pereira, M.D.
Dr. Brian J. G. Pereira, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. Ethan Holdaway
Mr. Ethan Holdaway
Investor Relations
Investor Relations
--
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Mr. Pablo Legorreta
Mr. Pablo Legorreta
Chairman of the Board
Chairman of the Board
--
--
Dr. Uma Sinha, Ph.D.
Dr. Uma Sinha, Ph.D.
Independent Director
Independent Director
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 11月8日 週六
更新時間: 11月8日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Tolerantia LLC
16.75%
Suvretta Capital Management, LLC
9.14%
Control Empresarial de Capitales, S.A. de C.V.
7.94%
Morgan Stanley Investment Management Inc. (US)
4.23%
BlackRock Mexico Operadora SA de CV SOFI
2.54%
其他
59.39%
持股股東
持股股東
佔比
Tolerantia LLC
16.75%
Suvretta Capital Management, LLC
9.14%
Control Empresarial de Capitales, S.A. de C.V.
7.94%
Morgan Stanley Investment Management Inc. (US)
4.23%
BlackRock Mexico Operadora SA de CV SOFI
2.54%
其他
59.39%
股東類型
持股股東
佔比
Corporation
24.70%
Hedge Fund
10.27%
Investment Advisor
10.23%
Investment Advisor/Hedge Fund
5.98%
Research Firm
2.84%
Individual Investor
1.92%
Endowment Fund
0.74%
Family Office
0.04%
Bank and Trust
0.04%
其他
43.25%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
180
38.60M
28.59%
-15.99M
2025Q2
187
92.52M
71.43%
-12.19M
2025Q1
188
90.99M
70.46%
-13.35M
2024Q4
184
92.39M
74.12%
+21.48M
2024Q3
176
90.75M
73.53%
+26.28M
2024Q2
216
81.85M
70.67%
+19.77M
2024Q1
231
37.73M
58.52%
-31.32M
2023Q4
239
39.92M
63.74%
-31.95M
2023Q3
236
64.28M
104.12%
-21.16M
2023Q2
223
59.02M
95.83%
-21.49M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Tolerantia LLC
22.62M
16.75%
--
--
Jun 03, 2025
Suvretta Capital Management, LLC
12.34M
9.14%
--
--
Jun 30, 2025
Control Empresarial de Capitales, S.A. de C.V.
10.72M
7.94%
+2.28M
+27.04%
Apr 22, 2025
Morgan Stanley Investment Management Inc. (US)
5.71M
4.23%
-4.33M
-43.14%
Jun 30, 2025
BlackRock Mexico Operadora SA de CV SOFI
3.43M
2.54%
--
--
Aug 31, 2025
Operadora de Fondos GBM S.A.B. de C.V.
2.45M
1.81%
--
--
Aug 31, 2025
Bleichroeder LP
2.00M
1.48%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.72M
1.27%
-4.60M
-72.83%
Jun 30, 2025
The Vanguard Group, Inc.
1.57M
1.16%
-3.64M
-69.92%
Jun 30, 2025
Culleton (Bruce)
1.54M
1.14%
+1.54M
--
Mar 17, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Schwab U.S. Small-Cap ETF
0.01%
ALPS Medical Breakthroughs ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Schwab U.S. Broad Market ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
Avantis US Equity ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
查看更多
Schwab U.S. Small-Cap ETF
佔比0.01%
ALPS Medical Breakthroughs ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
Schwab U.S. Broad Market ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Avantis US Equity ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
